PL3319626T3 - Szczepy bakteriofagów specyficznych wobec Proteus mirabilis oraz ich zastosowanie - Google Patents
Szczepy bakteriofagów specyficznych wobec Proteus mirabilis oraz ich zastosowanieInfo
- Publication number
- PL3319626T3 PL3319626T3 PL16753961T PL16753961T PL3319626T3 PL 3319626 T3 PL3319626 T3 PL 3319626T3 PL 16753961 T PL16753961 T PL 16753961T PL 16753961 T PL16753961 T PL 16753961T PL 3319626 T3 PL3319626 T3 PL 3319626T3
- Authority
- PL
- Poland
- Prior art keywords
- proteus mirabilis
- strains against
- bacteriophage strains
- against proteus
- bacteriophage
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/40—Viruses, e.g. bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413054A PL228858B1 (pl) | 2015-07-07 | 2015-07-07 | Szczep bakteriofagowy oraz jego zastosowanie do leczenia zakażeń wywoływanych przez bakterie Proteus mirabilis zwłaszcza przez szczepy lekooporne |
| PL413052A PL228856B1 (pl) | 2015-07-07 | 2015-07-07 | Szczep bakteriofagowy oraz jego zastosowanie do leczenia infekcji powodowanych przez bakterie Proteus mirabilis zwłaszcza przez szczepy lekooporne |
| PL413053A PL228857B1 (pl) | 2015-07-07 | 2015-07-07 | Szczep bakteriofagowy oraz jego zastosowanie do zwalczania bakterii Proteus mirabilis zwłaszcza szczepów lekoopornych |
| EP16753961.8A EP3319626B1 (en) | 2015-07-07 | 2016-07-07 | Bacteriophage strains against proteus mirabilis and uses thereof |
| PCT/IB2016/000974 WO2017006175A1 (en) | 2015-07-07 | 2016-07-07 | New bacteriophage strains against proteus mirabilis and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3319626T3 true PL3319626T3 (pl) | 2020-11-02 |
Family
ID=56740262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16753961T PL3319626T3 (pl) | 2015-07-07 | 2016-07-07 | Szczepy bakteriofagów specyficznych wobec Proteus mirabilis oraz ich zastosowanie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10435671B2 (pl) |
| EP (1) | EP3319626B1 (pl) |
| DK (1) | DK3319626T3 (pl) |
| PL (1) | PL3319626T3 (pl) |
| SI (1) | SI3319626T1 (pl) |
| WO (1) | WO2017006175A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112501189A (zh) * | 2020-12-30 | 2021-03-16 | 吉林大学 | 一种能杀死马链球菌马亚种的裂解酶及其医用用途 |
| CN112646785B (zh) * | 2020-12-30 | 2022-03-18 | 瑞科盟(青岛)生物工程有限公司 | 一株耐高温烈性变形杆菌噬菌体rdp-sa-20018及其应用 |
| CN115161288B (zh) * | 2021-11-24 | 2023-08-01 | 菲吉乐科(南京)生物科技有限公司 | 一种耐酸和耐高温的奇异变形杆菌噬菌体及其组合物、试剂盒及其应用 |
| CN116286678A (zh) * | 2023-04-20 | 2023-06-23 | 青岛诺安百特生物技术有限公司 | 一种变形杆菌噬菌体vB_PmiM_PF07及其应用 |
| WO2026021797A1 (en) * | 2024-07-26 | 2026-01-29 | Unilever Ip Holdings B.V. | A composition for biofilm disruption |
-
2016
- 2016-07-07 WO PCT/IB2016/000974 patent/WO2017006175A1/en not_active Ceased
- 2016-07-07 DK DK16753961.8T patent/DK3319626T3/da active
- 2016-07-07 US US15/742,127 patent/US10435671B2/en active Active
- 2016-07-07 SI SI201630733T patent/SI3319626T1/sl unknown
- 2016-07-07 PL PL16753961T patent/PL3319626T3/pl unknown
- 2016-07-07 EP EP16753961.8A patent/EP3319626B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3319626A1 (en) | 2018-05-16 |
| DK3319626T3 (da) | 2020-05-04 |
| SI3319626T1 (sl) | 2020-10-30 |
| WO2017006175A1 (en) | 2017-01-12 |
| US20190032022A1 (en) | 2019-01-31 |
| US10435671B2 (en) | 2019-10-08 |
| EP3319626B1 (en) | 2020-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273236A (en) | Pyrazolopyrimidine compounds and their uses | |
| IL258180B (en) | Heterocyclic compounds and their uses | |
| GB201714745D0 (en) | New compounds and uses | |
| SG11201706029VA (en) | Anti-senescence compounds and uses thereof | |
| ZA201805523B (en) | Antibacterial compounds and uses thereof | |
| GB201714734D0 (en) | New compounds and uses | |
| GB201714740D0 (en) | New compounds and uses | |
| IL253208A0 (en) | Converted DNase and its uses | |
| ZA201801052B (en) | Combinations and uses thereof | |
| PL3133153T3 (pl) | Nowy bakteriofag i zawierająca go kompozycja | |
| GB201616439D0 (en) | Compounds and uses | |
| ZA201705456B (en) | Benzoxaborole compounds and uses thereof | |
| PL3133151T3 (pl) | Nowy bakteriofag i zawierająca go kompozycja | |
| GB201504763D0 (en) | Compounds and uses | |
| PL3319626T3 (pl) | Szczepy bakteriofagów specyficznych wobec Proteus mirabilis oraz ich zastosowanie | |
| GB201714736D0 (en) | New compounds and uses | |
| IL254241A0 (en) | Etv2 and its uses | |
| IL253459A0 (en) | Isoergoline compounds and their uses | |
| GB201712110D0 (en) | New compounds and uses | |
| GB201718875D0 (en) | Autophagy-inhibiting compounds and uses thereof | |
| PL3135761T3 (pl) | Nowy bakteriofag i zawierająca go kompozycja | |
| PL3440200T3 (pl) | Zmodyfikowany bakteriofag | |
| PL2944740T3 (pl) | Układ i korpus łączący | |
| GB201508028D0 (en) | Sandfalls and the like | |
| GB201720092D0 (en) | New Compounds and uses |